Ticker > Company >

Ravelcare share price

Ravelcare Ltd.

BSE: 544629 SECTOR: Trading  681   0   0

172.40
-9.05 (-4.99%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 172.4

Today's Low

₹ 172.4

52 Week High

₹ 208.95

52 Week Low

₹ 181.45

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

118.25 Cr.

Enterprise Value

117.54 Cr.

No. of Shares

0.69 Cr.

P/E

22.53

P/B

3.43

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  50.22

CASH

0.7 Cr.

DEBT

0 Cr.

Promoter Holding

72.94 %

EPS (TTM)

₹  7.65

Sales Growth

13.09%

ROE

67.97 %

ROCE

91.42%

Profit Growth

4.45 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Index Presence

The company is present in 1Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year13.09%
3 Year216.4%
5 YearNA

Profit Growth

1 Year4.45%
3 Year174.2%
5 YearNA

ROE%

1 Year67.97%
3 Year87.46%

ROCE %

1 Year91.42%
3 Year181.24%

Debt/Equity

0

Price to Cash Flow

-214.88

Interest Cover Ratio

172.1338

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2025 72.94 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 216.398082732211% for the Past 3 years.
  • The company has significantly decreased its debt by 0.0381 Cr.
  • Company has been maintaining healthy ROE of 87.4646333333333% over the past 3 years.
  • Company has been maintaining healthy ROCE of 181.240566666667% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 172.1338.
  • The company has an efficient Cash Conversion Cycle of -23.0334 days.
  • Company has a healthy liquidity position with current ratio of 2.61.
  • The company has a high promoter holding of 72.94%.

 Limitations

  • Company has negative cash flow from operations of -0.5503.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Quarterly Result (All Figures in Cr.)

 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 0.79 3.49 22.09 24.98
Total Expenditure 1.01 2.98 15.35 18.12
Operating Profit -0.22 0.51 6.74 6.86
Other Income 0 0 0.19 0.32
Interest 0.01 0 0.1 0.04
Depreciation 0 0 0.02 0.1
Exceptional Items 0 0 0 0
Profit Before Tax -0.23 0.51 6.81 7.03
Tax 0.06 0.09 1.78 1.79
Net Profit -0.28 0.42 5.02 5.25
Adjusted EPS (Rs.) -0.56 0.83 10.04 10.48

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 0.01 0.01 0.01 5.01
Total Reserves -0.41 0.07 5.09 5.34
Borrowings 0 0 0 0
Other N/C liabilities 0.06 0 0.04 0
Current liabilities 0.42 1.67 4.32 2.56
Total Liabilities 0.07 1.74 9.45 12.9
Assets
Net Block 0 0.01 0.22 0.16
Capital WIP 0 0 0 0
Intangible WIP 0 0 0 0
Investments 0 0 0.79 3.07
Loans & Advances 0 0.01 0.02 0.03
Other N/C Assets 0 0 6.08 2.96
Current Assets 0.07 1.72 2.33 6.68
Total Assets 0.07 1.74 9.45 12.9
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations -0.23 0.51 6.81 7.03
Adjustment 0.01 0 -0.16 -0.19
Changes in Assets & Liabilities -0.19 0.49 1.21 -5.7
Tax Paid 0 0 -1.43 -1.69
Operating Cash Flow -0.41 1 6.43 -0.55
Investing Cash Flow 0 -0.01 -6.92 1.18
Financing Cash Flow 0.41 -0.01 -0.38 -0.04
Net Cash Flow 0 0.98 -0.87 0.59

Corporate Actions

Investors Details

PARTICULARS Dec 2025%
promoters 72.94
anita mahesh varma 2.92
ayush mahesh varma 64.15
jyoti aggarwal 0.01
kritika aggarwal 2.93
maheshkumar ramchandra va... 2.93
PARTICULARS Dec 2025%
investors 27.06
finvesta first 1.12
j4s venture fund-i 1.12
lighthouse canton special... 1.12
nav capital vcc - nav cap... 2.04
navbharat investment trus... 1.12
s s corporate securities ... 1.37
viney growth fund 1.22

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Ravelcare Stock Price Analysis and Quick Research Report. Is Ravelcare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Ravelcare. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Ravelcare has a PE ratio of 22.5338857882285 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Ravelcare has ROA of 46.9515% which is a good sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Ravelcare has a Current ratio of 2.61.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Ravelcare has a ROE of 67.9741%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Ravelcare has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Ravelcare has reported revenue growth of 13.0891% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Ravelcare for the current financial year is 27.4463647318337%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Ravelcare is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Ravelcare is Rs 7.6507. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Ravelcare in Ticker for free. Also, one can get the intrinsic value of Ravelcare by using Valuation Calculators, which are available with a Finology ONE subscription. 

Ravelcare FAQs

Q1. What is Ravelcare share price today?
Ans: The current share price of Ravelcare is Rs 172.4.

Q2. What is the market capitalisation of Ravelcare?
Ans: Ravelcare has a market capitalisation of Rs 118.24916 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Ravelcare?
Ans: The PE ratio of Ravelcare is 22.5338857882285 and the P/B ratio of Ravelcare is 3.43290209657924, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Ravelcare share?
Ans: The 52-week high share price of Ravelcare is Rs 208.95, and the 52-week low share price of Ravelcare is Rs 181.45.

Q5. Does Ravelcare pay dividends?
Ans: Currently, Ravelcare does not pay dividends. Dividend yield of Ravelcare is around 0%.

Q6. What are the face value and book value of Ravelcare shares?
Ans: The face value of Ravelcare shares is Rs 10, while the book value per share of Ravelcare is around Rs 50.2199. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Ravelcare?
Ans: Ravelcare has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Ravelcare?
Ans: The ROE of Ravelcare is 67.9741% and ROCE of Ravelcare is 91.4156%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Ravelcare a good buy for the long term?
Ans: The Ravelcare long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Ravelcare undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Ravelcare appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Ravelcare’s financials?
Ans: You can review Ravelcare’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Ravelcare
X